Los puntos clave no están disponibles para este artículo en este momento.
Introduction 0.0001), forearm (€951 vs. €947, p=0.022), foot (€565 vs. €443, p0.0001), and ankle fractures (€1,968 vs. €1,063, p0.0001). Conclusion: The direct healthcare costs of fractures were higher for T2D. Disclosure A.V. Kvist: None. M. Frost: Research Support; Novo Nordisk A/S. Stock/Shareholder; Novo Nordisk A/S. A.M. Burden: None. P. Vestergaard: None. T. Kristrensen: None. Funding European Union’s Horizon 2020 research and innovation program under the H2020 Marie Skłodowska-Curie Actions grant 860898.
Kvist et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: